| 1 |
vitamin K antagonists
(618 times)
|
Vascular Diseases
(158 times)
|
AF (211 times)
NOACs (165 times)
VTE (97 times)
|
2004 Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX.
|
| 2 |
enoxaparin-vitamin K antagonists
(1 time)
|
Hematology
(1 time)
|
---
|
2016 Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists.
|
| 3 |
Vit K antagonists
(1 time)
|
Cardiology
(1 time)
|
AF (1 time)
DOACs (1 time)
HHF (1 time)
|
2018 Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
|
| 4 |
vitamin K analogues
(1 time)
|
Health Services
(1 time)
|
CAT (1 time)
DOACs (1 time)
IDPTP (1 time)
|
2017 Advances in managing and preventing thromboembolic disease in cancer patients.
|
| 5 |
vitamin K antagonist oral anticoagulants
(1 time)
|
Medicine
(1 time)
|
AF (1 time)
CI (1 time)
NOACs (1 time)
|
2015 Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis.
|
| 6 |
vitamin K anticoagulants
(1 time)
|
Medicine
(1 time)
|
NOACs (1 time)
OCTA (1 time)
|
2018 The potential for evaluating the effects of intensified antithrombotic therapy using retinal optical coherence tomography angiography.
|
| 7 |
Vitamin K-dependent antagonists
(1 time)
|
Cardiology
(1 time)
|
NOACs (1 time)
|
2016 Real Data on Effectiveness, Tolerability and Safety of New Oral Anticoagulant Agents: Focus on Dabigatran.
|
| 8 |
vitamin K-dependent, drugs interfering with the effects of the vitamin
(1 time)
|
Hematology
(1 time)
|
ACS (1 time)
NOACs (1 time)
TXA2 (1 time)
|
2016 Individualized antithrombotic therapy.
|
A Search Service for Abbreviation / Long Form